Ginkgo Bioworks Insider Sells Shares to Cover Tax Obligations
1 report, 1 independent
Updated Oct 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jason Kelly, co-founder of Ginkgo Bioworks, sold 45,682 shares of the company's stock on October 19th. The transaction, valued at $463,215.48, was made to cover tax withholding obligations related to vesting equity awards. Kelly sold the shares at an average price of $10.14 per share.
From tickerreport.com
Why it matters
The sale occurred while Ginkgo Bioworks recently reported revenue of $20.16 million for the quarter, which was below the consensus estimate of $24.05 million. The company did, however, report an EPS of ($0.75), topping analysts’ consensus estimate of ($0.90).
From tickerreport.com
Who's involved
- Jason KellyCo-founder, CEO, and minority owner of Ginkgo Bioworks
- Ginkgo BioworksAmerican biotechnology company whose shares were sold
Keep exploring
The entities involved
-
Ginkgo Bioworks
American biotechnology company
Nothing else this week.
-
Jason Kelly
American writer, stock market specialist
Nothing else this week.